How to treat hypertension in diabetic patients.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D048909:Diabetes Complications; D003928:Diabetic Nephropathies / Q000150:complications; D004232:Diuretics; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D013565:Sympatholytics / Q000008:administration & dosage / Q000009:adverse effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D002800:Cholinesterase Inhibitors; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D014665:Vasodilator Agents